This site is intended for Healthcare Professionals only.

Pharmacy Contraceptive Service launch postpone from January 2023 to early 2023


Share post:

The specification for the Pharmacy Contraceptive Service has been launched for pharmacy contractors to download from the NHSBSA website.

However, the service will not start on 11th January 2023, as originally planned, but it is expected to commence in early 2023, revealed the Pharmaceutical Services Negotiating Committee (PSNC).

It added: “The exact start date is yet to be agreed, as now the service specification has been published, community pharmacy IT system suppliers need time to develop support for the service, so this is available to contractors from the service commencement date.”

Commenting on the publication of the service specification, Alastair Buxton, Director of NHS Services, at PSNC said: “When time in their busy professional lives allows, the publication of the service specification ahead of the start of the new service provides contractors and their teams with an opportunity to learn more about it and to consider whether it is something they will have the capacity to provide in due course.

Understanding the massive pressure of patient demand, a funding squeeze and workforce shortages on pharmacies, the committee don’t expect many pharmacies will have the capacity to provide the service as soon as it commences.

“We sought a delay to the start of the service to allow time for the necessary IT support to be developed, so where contractors do have the capacity to provide the service, they can do so with fully functioning IT to support its delivery.”



Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

ABPI: Increased pharma exports could boost GDP by £16.3 billion

ABPI urges political leaders to enhance healthcare and economic growth through strategic partnership The Association of the British Pharmaceutical...

The Importance Of Expanding Access To Dental Care For Rural And Undeserved Populations

In many rural areas and underserved neighborhoods, a critical issue is quietly emerging. Although often overlooked, its effects...

BGMA: More than 50% of UK generics face shortages without licensed alternatives

Brexit blamed by BGMA CE, Mark Samuels, as UK faces critical shortages in generic drug supply A recent report...

Paul Burden elected BGMA Vice-Chair, bringing 25 years of industry leadership

Veteran of off-patent sector to drive strategic engagement and patient access initiatives at BGMA The British Generic Manufacturers Association...